Literature DB >> 15087600

4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Francesco Burzotta1, Licia Iacoviello, Augusto Di Castelnuovo, Roberto Zamparelli, Andria D'Orazio, Concetta Amore, Rocco Schiavello, Maria Benedetta Donati, Attilio Maseri, GianFederico Possati, Felicita Andreotti.   

Abstract

BACKGROUND AND
OBJECTIVE: The 4G/5G plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism has been associated with basal PAI-1 levels, with ischemic heart disease, and with adverse prognosis in critically ill patients. We hypothesized it might also influence the acute-phase levels of PAI-1 following coronary bypass surgery.
METHODS: In 111 consecutive patients undergoing elective coronary bypass surgery, 4G/5G genotyping and serial plasma PAI-1 activity and antigen levels were prospectively measured before surgery, daily up to 72 h, and at discharge. The inflammatory reaction was additionally assessed by white cell count, fibrinogen, interleukin-6, and C-reactive protein levels.
RESULTS: PAI-1 activity and antigen concentrations increased approximately two-fold after surgery, peaking at 48 hours. Carriers of the 4G-allele, compared with 5G/5G homozygotes, showed approximately 20% higher PAI-1 activity and antigen both preoperatively ( P = 0.007 and P = 0.035) and after surgery. White cell count, fibrinogen, interleukin-6, and C-reactive protein values did not differ significantly according to genotypic groups. In multivariate analysis, the 4G/5G genotype was the only significant modulator of postoperative PAI-1 activity (P = 0.003) and the main significant modulator of postoperative PAI-1 antigen (P = 0.013). No significant interaction was found between the effects of time and genotype on postoperative PAI-1. This indicates that the association between 4G/5G and acute-phase PAI-1 levels is secondary to the genotype-related difference of baseline PAI-1.
CONCLUSIONS: Postoperative PAI-1 concentrations of patients undergoing elective coronary bypass surgery are higher in carriers of the 4G-allele than in 5G/5G homozygotes as a result of higher baseline values. Knowledge of 4G/5G status may be useful to predict acute-phase PAI-1 concentrations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15087600     DOI: 10.1023/B:THRO.0000024052.79415.62

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

1.  The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis.

Authors:  L Iacoviello; F Burzotta; A Di Castelnuovo; F Zito; R Marchioli; M B Donati
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

2.  4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction.

Authors:  F Burzotta; A Di Castelnuovo; C Amore; A D'Orazio; R Di Bitondo; M B Donati; L Iacoviello
Journal:  Thromb Haemost       Date:  1998-02       Impact factor: 5.249

3.  Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation.

Authors:  O Kucuk; H C Kwaan; J Frederickson; L Wade; D Green
Journal:  Am J Hematol       Date:  1986-11       Impact factor: 10.047

4.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.

Authors:  P W Hermans; M L Hibberd; R Booy; O Daramola; J A Hazelzet; R de Groot; M Levin
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

5.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.

Authors:  J Stibbe; C Kluft; E J Brommer; M Gomes; D S de Jong; J Nauta
Journal:  Eur J Clin Invest       Date:  1984-10       Impact factor: 4.686

Review 6.  A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.

Authors:  M H Prins; J Hirsh
Journal:  Arch Intern Med       Date:  1991-09

7.  Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.

Authors:  J A Páramo; J Rifón; R Llorens; J Casares; M J Paloma; E Rocha
Journal:  Haemostasis       Date:  1991

8.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

9.  The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.

Authors:  S Ye; F R Green; P Y Scarabin; V Nicaud; L Bara; S J Dawson; S E Humphries; A Evans; G Luc; J P Cambou
Journal:  Thromb Haemost       Date:  1995-09       Impact factor: 5.249

10.  Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.

Authors:  K W Klinger; R Winqvist; A Riccio; P A Andreasen; R Sartorio; L S Nielsen; N Stuart; P Stanislovitis; P Watkins; R Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  4 in total

1.  Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease.

Authors:  Ahmet Var; Ozan Utük; Sinem Akçali; Tamer Sanlidağ; Bekir S Uyanik; Gönül Dinç
Journal:  Mol Biol Rep       Date:  2009-01-03       Impact factor: 2.316

2.  PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass.

Authors:  Agnese Ozolina; Eva Strike; Inta Jaunalksne; Angelika Krumina; Lars J Bjertnaes; Indulis Vanags
Journal:  BMC Anesthesiol       Date:  2012-10-30       Impact factor: 2.217

3.  Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma.

Authors:  Georg Mossböck; Martin Weger; Christoph Faschinger; Otto Schmut; Wilfried Renner
Journal:  Mol Vis       Date:  2008-07-04       Impact factor: 2.367

4.  Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.

Authors:  Agnese Ozolina; Eva Strike; Liene Nikitina-Zake; Inta Jaunalksne; Angelika Krumina; Romans Lacis; Lars J Bjertnaes; Indulis Vanags
Journal:  BMC Anesthesiol       Date:  2015-09-04       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.